Skip to content

Sabre SABR Interest Income (Expense), Nonoperating

Interest Income (Expense), Nonoperating at other companies

ResMed logo
ResMedRMD

Other financials

Income statement

See full
Revenue$760.3M+8.3%
Gross profit$425.3M+7.2%
Operating income$115.9M+26.8%
Net income$8.0M-77.5%
EPS (diluted)$0.02-77.8%

Balance sheet

See full
Cash & equivalents$643.6M-1.2%
Total debt$4.3B-16.6%
Total equity-$1.1B-78.6%
Total assets$4.3B-7.4%

Cash flow

See full
Operating cash flow-$134.2M-66.4%
CapEx$21.2M+25.8%
Free cash flow-$155.4M-59.4%

Valuation

See full
Market cap$739.24M-27.5%
Enterprise value$4.36B-20.5%
P/E1.2×
P/S0.3×-0.1×

Profitability

See full
Gross margin56.3%-1.3pp
Operating margin11.3%+2.4pp
Net margin20.1%+14.7pp
FCF margin-9.7%-2.8pp

Returns & leverage

See full
Debt / equity4.8×
Current ratio0.9×-0.2×

Where this comes from

Reported directly by Sabre in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.

The official record: Sabre’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sabre's interest income (expense), nonoperating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sabre's interest income (expense), nonoperating?
Sabre (SABR) reported interest income (expense), nonoperating of -$122.96M in Q1 2026.
How has Sabre's interest income (expense), nonoperating changed year-over-year?
Sabre's interest income (expense), nonoperating decreased by 12.0% year-over-year, from -$109.79M to -$122.96M.
What is the long-term trend for Sabre's interest income (expense), nonoperating?
Over 3 years (2022 to 2025), Sabre's interest income (expense), nonoperating has grown at a 14.9% compound annual growth rate (CAGR), from -$295.23M to -$447.83M.